GlassScriptPhysician profile
Rexford A Babilah
NPI 1689869968
$15,645.52
in general payments reported to CMS, 2019-2025
64 companies · $2,975 in 2025
The $2,975 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $1,808 · 2021: $2,432 · 2022: $2,481 · 2023: $2,143 · 2024: $2,014 · 2025: $2,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,101 · Education: $30.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,101.20 |
| Education | $30.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,688.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,505.13 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,235.34 | 2021-2025 | Ubrelvy, Qulipta, Linzess |
| Lilly USA, LLC | $912.27 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $886.96 | 2019-2025 | |
| Amgen INC. | $852.65 | 2019-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $808.67 | 2021-2025 | |
| Corcept Therapeutics | $698.07 | 2021-2025 | Korlym |
| Astellas Pharma US INC | $560.03 | 2019-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $553.65 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $515.13 | 2019-2025 | |
| Glaxosmithkline, LLC. | $379.38 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lundbeck LLC | $296.10 | 2020-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.04 | 2019-2025 | Jardiance, Tradjenta |
| Amarin Pharma, INC. | $263.31 | 2019-2022 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $248.44 | 2023-2025 | Gemtesa |
| Horizon Therapeutics Plc | $227.72 | 2019-2023 | Krystexxa |
| Optinose US, INC. | $224.56 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $207.44 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $178.01 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $175.33 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Janssen Pharmaceuticals, INC | $173.06 | 2019-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $172.80 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $157.64 | 2020-2022 | |
| Ardelyx, INC. | $156.67 | 2024-2025 | Ibsrela |
| Avanir Pharmaceuticals, INC. | $146.18 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $140.90 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $129.25 | 2019-2025 | Evkeeza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.98 | 2019-2025 | Xifaxan |
| Biohaven Pharmaceuticals, INC. | $128.95 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $127.49 | 2019-2023 | Linzess |
| Otsuka America Pharmaceutical, INC. | $122.38 | 2023-2025 | Rexulti, Nuedexta |
| Organogenesis INC. | $100.03 | 2025 | Puraply Wound Matrix, Simplimax |
| Xeris Pharmaceuticals, INC. | $92.55 | 2025 | Recorlev |
| Exact Sciences Corporation | $90.04 | 2024-2025 | Cologuard Collection Kit |
| Global Blood Therapeutics, INC. | $88.32 | 2021-2022 | |
| Allergan, INC. | $83.55 | 2019-2020 | |
| Boston Scientific Corporation | $79.73 | 2024-2025 | Bodyguardian, Wavewriter Alpha Prime 16 |
| Biohaven Pharmaceutical Holding Company LTD. | $74.54 | 2022 | |
| Sanofi-Aventis U.S. LLC | $73.12 | 2020-2023 | |
| Alnylam Pharmaceuticals INC. | $64.10 | 2023-2024 | Givlaari |
| Csl Behring | $57.91 | 2025 | Haegarda, Andembry |
| Axsome Therapeutics, INC. | $50.44 | 2025 | Symbravo |
| Antares Pharma, INC. | $46.21 | 2021-2022 | |
| Chiesi USA, INC. | $41.31 | 2025 | Juxtapid |
| Esperion Therapeutics, INC. | $40.48 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $39.59 | 2025 | Inspire |
| Nevro Corp. | $26.90 | 2021 | |
| Hologic Sales and Service, LLC | $25.11 | 2025 | Aptima |
| Eisai INC. | $24.52 | 2019-2021 | |
| Shield Therapeutics INC | $24.24 | 2022 | |
| Genentech USA, INC. | $24.18 | 2021 | |
| Smith+Nephew, INC. | $22.40 | 2025 | Collagenase Santyl |
| Medtronic, INC. | $21.35 | 2023 | Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $17.95 | 2025 | Xhance, Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $16.89 | 2021 | |
| Phadia US INC. | $16.70 | 2019 | |
| Currax Pharmaceuticals LLC | $16.38 | 2023 | Contrave, Onzetra Xsail |
| Zyla Life Sciences, INC. | $16.24 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $16.14 | 2020 | |
| Gilead Sciences, INC. | $15.70 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.61 | 2023 | Edarbi |
| Hikma Pharmaceuticals USA | $15.21 | 2024 | Ryaltris |
| Seqirus USA INC | $15.14 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rexford Babilah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.